BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 18249119)

  • 1. The use of chemotherapy in patients with gliomas: patterns of care in Victoria from 1998-2000.
    Cher L; Rosenthal MA; Drummond KJ; Dally M; Murphy M; Ashley D; Thursfield V; Giles GG
    J Clin Neurosci; 2008 Apr; 15(4):398-401. PubMed ID: 18249119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy management of patients diagnosed with glioma in Victoria (1998-2000): a retrospective cohort study.
    Dally M; Rosenthal M; Drummond K; Murphy M; Cher L; Ashley D; Thursfield V; Giles G
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):318-24. PubMed ID: 19624300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain stem gliomas: patterns of care in Victoria from 1998-2000.
    Rosenthal MA; Ashley DM; Drummond KJ; Dally M; Murphy M; Cher L; Thursfield V; Giles GG
    J Clin Neurosci; 2008 Mar; 15(3):237-40. PubMed ID: 18226529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of high grade glioma - long term survival.
    Stylli SS; Kaye AH; MacGregor L; Howes M; Rajendra P
    J Clin Neurosci; 2005 May; 12(4):389-98. PubMed ID: 15925768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
    Beauchesne PD; Taillandier L; Bernier V; Carnin C
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical management of high-grade gliomas.
    Hsieh JC; Lesniak MS
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S33-9. PubMed ID: 16274269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
    Hargrave D
    Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-operation is a safe and effective therapeutic strategy in recurrent WHO grade II gliomas within eloquent areas.
    Martino J; Taillandier L; Moritz-Gasser S; Gatignol P; Duffau H
    Acta Neurochir (Wien); 2009 May; 151(5):427-36; discussion 436. PubMed ID: 19337688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for malignant gliomas.
    Kreisl TN
    Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of DNA repair mechanisms to determining chemotherapy response in high-grade glioma.
    Parkinson JF; Wheeler HT; McDonald KL
    J Clin Neurosci; 2008 Jan; 15(1):1-8. PubMed ID: 18037296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.
    Kong DS; Lee JI; Park K; Kim JH; Lim DH; Nam DH
    Cancer; 2008 May; 112(9):2046-51. PubMed ID: 18338759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A survey of neurosurgeons' policies and attitudes regarding the disclosure of a diagnosis of glioma and the decision to pursue end-of-life care in glioma patients].
    Narita Y; Miyakita Y; Momota H; Miyahara R; Shibui S
    No Shinkei Geka; 2009 Oct; 37(10):973-81. PubMed ID: 19882957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gliomas in the elderly].
    Laigle-Donadey F; Navarro S; Delattre JY
    Rev Neurol (Paris); 2008; 164(6-7):542-6. PubMed ID: 18565352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of life.
    Brown PD; Decker PA; Rummans TA; Clark MM; Frost MH; Ballman KV; Arusell RM; Buckner JC
    Am J Clin Oncol; 2008 Apr; 31(2):163-8. PubMed ID: 18391601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EORTC 22972-26991/MRC BR10 trial: fractionated stereotactic boost following conventional radiotherapy of high grade gliomas. Clinical and quality-assurance results of the stereotactic boost arm.
    Baumert BG; Brada M; Bernier J; Kortmann RD; Dehing-Oberije C; Collette L; Davis JB
    Radiother Oncol; 2008 Aug; 88(2):163-72. PubMed ID: 18455252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of glioma in Victoria (1998-2000): retrospective cohort study.
    Rosenthal MA; Drummond KJ; Dally M; Murphy M; Cher L; Ashley D; Thursfield V; Giles GG
    Med J Aust; 2006 Mar; 184(6):270-3. PubMed ID: 16548830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterpoint--chemotherapy is useful in the treatment of gliomas.
    Drummond K
    J Clin Neurosci; 2000 Sep; 7(5):466-7. PubMed ID: 10942678
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemotherapy could be given at patients' workplace.
    Carter JM
    BMJ; 2001 Aug; 323(7308):340-1. PubMed ID: 11548678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.